Uptravi

Company:
Janssen Sciences Ireland (a Johnson & Johnson Company)
Status:
Updated
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Selexipag
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/15/1083/002

200 microgram(s)

B01AC27

Film-coated tablet

EU/1/15/1083/004

400 microgram(s)

B01AC27

Film-coated tablet

EU/1/15/1083/005

600 microgram(s)

B01AC27

Film-coated tablet

EU/1/15/1083/006

800 microgram(s)

B01AC27

Film-coated tablet

EU/1/15/1083/007

1000 microgram(s)

B01AC27

Film-coated tablet

EU/1/15/1083/008

1200 microgram(s)

B01AC27

Film-coated tablet

EU/1/15/1083/009

1400 microgram(s)

B01AC27

Film-coated tablet

EU/1/15/1083/010

1600 microgram(s)

B01AC27

Film-coated tablet